Systematic Reviews & Meta-analysis
M-A | Risk of recurrence and reintervention after uterine-sparing interventions for symptomatic adenomyosis
15 Mar, 2023 | 15:05h | UTC
Proposed triggers for retiring a living systematic review
15 Mar, 2023 | 15:02h | UTCProposed triggers for retiring a living systematic review – BMJ Evidence-Based Medicine
M-A | Comparison of pediatric emergency department visits for attempted suicide before and during the COVID-19 pandemic
15 Mar, 2023 | 14:56h | UTC
M-A | Pretest probability assessment and D-Dimer are preferred for the initial evaluation of suspected PE in pregnant women
15 Mar, 2023 | 14:50h | UTC
M-A | Ionizing radiation and cardiovascular disease
14 Mar, 2023 | 13:49h | UTCIonising radiation and cardiovascular disease: systematic review and meta-analysis – The BMJ
News Release: Low dose radiation linked to increased lifetime risk of heart disease – BMJ Newsroom
SR | Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how
14 Mar, 2023 | 13:46h | UTC
SR | Do treatment effects in randomized trials differ when using active placebo compared to standard placebo?
14 Mar, 2023 | 13:25h | UTC
Commentary on Twitter
? In our recent #Cochrane Review, we look at the impact of using #ActivePlacebo control versus standard placebo in randomised drug trials. https://t.co/7VwTOSRKxF#Blinding #Unblinding #Placebo #Bias @cochranemthds @AsgerPaludan @ChrisPaWer
1/10
— David Laursen (@LaursenDavid) March 8, 2023
SR | Parathyroidectomy for adults with primary hyperparathyroidism
14 Mar, 2023 | 13:22h | UTCParathyroidectomy for adults with primary hyperparathyroidism – Cochrane Library
Summary: Parathyroidectomy for adults with primary hyperparathyroidism – Cochrane Library
M-A | Routine anaerobic coverage for aspiration pneumonia: limited evidence of benefit
13 Mar, 2023 | 15:03h | UTCSummary: Treating aspiration pneumonia with antibiotics that cover anaerobic bacteria has become common practice in many services, but recent studies suggest that this may not necessarily improve prognosis.
Out of 2523 publications, this systematic review and meta-analysis only included one randomized control trial and two observational studies. The study found no clear benefit of anaerobic coverage and concluded that there is not enough data to evaluate the necessity of anaerobic coverage in the antibiotic treatment of aspiration pneumonia.
The authors suggest that covering anaerobic bacteria with antibiotics may not be needed as an initial treatment for aspiration pneumonia if there is no formation of abscess or empyema and the patient has good oral hygiene.
Related: BTS clinical statement on aspiration pneumonia – Thorax
M-A | Strength of association between comorbidities and asthma
13 Mar, 2023 | 15:01h | UTCSummary: The study investigated the strength of association between comorbidities and asthma, as the presence of comorbidities is related to poor asthma outcomes. A comprehensive literature search was conducted for observational studies reporting data on comorbidities in asthma and nonasthma populations.
A total of 5,493,776 subjects were analyzed, and several comorbidities were found to be strongly or very strongly associated with asthma and severe asthma, including allergic conjunctivitis, allergic rhinitis, bronchiectasis, hypertensive cardiomyopathy, nasal congestion, COPD, and other chronic respiratory diseases.
The study supports the relevance of individualized strategies for disease management that look beyond asthma and suggests a comprehensive approach should be used to assess whether poor symptom control is related to uncontrolled asthma or other underlying comorbidities.
SR | Surgical treatments for epilepsies in children aged 1–36 months
10 Mar, 2023 | 14:21h | UTCSurgical Treatments for Epilepsies in Children Aged 1–36 Months: A Systematic Review – Neurology
Commentary on Twitter
Tsou and colleagues summarize findings of a systematic review commissioned by the @AmEpilepsySoc to assess evidence and identify evidence gaps for surgical treatments for #epilepsy in children aged 1–36 months without infantile spasms. Read the article: https://t.co/Q1WW8Yy0Jf pic.twitter.com/Ko1c27x6cw
— Neurology Journal (@GreenJournal) January 9, 2023
WHO Meta-Analysis | Saturated fat and trans-fat intakes and their replacement with other macronutrients
9 Mar, 2023 | 14:24h | UTC
Commentary on Twitter
Saturated fat and trans-fat intakes
and their replacement with other
macronutrients
published on behalf @WHO https://t.co/fNXmKwWOMQ pic.twitter.com/0Qi8PNqyqq— Lukas Schwingshackl (@LSchwingshackl) March 6, 2023
Evidence Analysis | Menière’s disease: experience, evidence gaps & treatment choices
9 Mar, 2023 | 14:21h | UTCMenière’s disease: experience, evidence gaps & treatment choices – Evidently Cochrane
New Cochrane Reviews:
Systemic pharmacological interventions for Ménière’s disease – Cochrane Library
Intratympanic gentamicin for Ménière’s disease – Cochrane Library
Intratympanic corticosteroids for Ménière’s disease – Cochrane Library
Positive pressure therapy for Ménière’s disease – Cochrane Library
Lifestyle and dietary interventions for Ménière’s disease – Cochrane Library
Surgical interventions for Ménière’s disease – Cochrane Library
SR | Spinal cord stimulation for low back pain provides no sustained clinical benefits compared to placebo
9 Mar, 2023 | 14:12h | UTCSummary: Spinal cord stimulation (SCS) is a surgical procedure used to treat persistent low back pain by sending electrical signals via implanted electrodes into the spinal cord. The review included 13 studies (randomized controlled trials and cross‐over trials) with 699 participants.
Most of the studies were focused on short-term effects (less than one month), but the review found it is uncertain whether spinal cord stimulation can improve outcomes in the immediate term compared with placebo. At six months, SCS probably does not improve back or leg pain, function, or quality of life compared with placebo, with moderate certainty of evidence. Adverse events were also reported, including infections, neurological damage, and lead migration requiring repeated surgery.
The review concluded that the data does not support the use of SCS to manage low back pain outside a clinical trial. Current evidence suggests SCS probably does not have sustained clinical benefits that would outweigh the costs and risks of this surgical intervention.
Article: Spinal cord stimulation for low back pain – Cochrane Library
Summary: Spinal cord stimulation for low back pain – Cochrane Library
Commentary from the author on Twitter
Our Cochrane review on spinal cord stimulators for #backpain out today.
Bottom line:
-Mod certainty evidence of no benefit vs placebo in medium term
-Uncertain if benefit on pain in immediate term
-Adverse events (infection, re-operation) commonhttps://t.co/lNJQeN96Zs— Adrian Traeger (@adrian_traeger) March 7, 2023
SR | There is insufficient evidence to recommend pharmacological treatments for central sleep apnea in adults
9 Mar, 2023 | 14:01h | UTCPharmacological treatment for central sleep apnoea in adults – Cochrane Library
Summary: Medicines for central sleep apnoea in adults – Cochrane Library
M-A | Efficacy of mesalamine in irritable bowel syndrome
9 Mar, 2023 | 13:56h | UTC
SR | Ultrasound‐guided arterial cannulation in the pediatric population
7 Mar, 2023 | 13:15h | UTCSummary:
This updated systematic review analyzed nine randomized controlled trials comparing ultrasound guidance to traditional methods of locating arteries for cannulation, such as palpation and Doppler auditory assistance.
The review found that ultrasound guidance probably improves first-attempt success rates, reduces the risk of complications such as hematoma formation, improves success rates within two attempts and the overall rate of successful cannulation, and reduces the number of attempts and duration of the cannulation procedure.
However, the review also notes that the evidence is only of moderate certainty due to the inability to mask the doctors performing the cannulation and the limited number of children studied. More research is needed to confirm the benefits of ultrasound guidance for arterial cannulation in different age groups of children.
Article: Ultrasound‐guided arterial cannulation in the paediatric population – Cochrane Library
Summary: Ultrasound use for insertion of arterial catheters in children – Cochrane Library
SR | Intermittent phototherapy versus continuous phototherapy for neonatal jaundice
7 Mar, 2023 | 12:59h | UTCSummary:
Phototherapy is a widely accepted first-line therapy for neonatal jaundice, and while continuous phototherapy is traditionally used, intermittent phototherapy has been proposed as an equally effective alternative with practical advantages such as improved maternal feeding and bonding. This systematic review compared intermittent vs. continuous phototherapy’s effectiveness and safety in treating neonatal jaundice.
The study included 12 randomized controlled trials involving 1600 infants, and found little or no difference between intermittent and continuous phototherapy in reducing bilirubin levels. Continuous phototherapy was found to be more effective in preterm infants, but the risks and potential benefits are unknown.
The review concludes that while there are theoretical benefits to intermittent regimens, large, well-designed, prospective trials are needed to determine whether intermittent and continuous phototherapy are equally effective and safe in both preterm and term infants.
Article: Intermittent phototherapy versus continuous phototherapy for neonatal jaundice – Cochrane Library
Summary: Intermittent phototherapy versus continuous phototherapy for neonatal jaundice – Cochrane Library
M-A | Oral iron supplementation and anemia in children according to schedule, duration, dose and cosupplementation
7 Mar, 2023 | 12:53h | UTCSummary:
The article is a systematic review and meta-analysis of 129 randomized trials on iron supplementation and anemia in children. The study aimed to identify the optimal schedule, duration, dose, and cosupplementation regimen for iron supplementation in children and adolescents aged under 20 years.
The results showed that frequent (3-7 times/week) and intermittent (1-2 times/week) iron supplementation could be equally effective at increasing hemoglobin and decreasing anemia, iron deficiency, and iron deficiency anemia.
The study supports WHO recommendations regarding the frequency, duration, and dose of iron supplementation, including 3 months annually of daily oral iron supplementation for children aged 6 months to 12 years living in regions with a high burden of anemia. However, it also suggests that weekly iron supplementation might be considered an alternative to the recommended daily regimen in some contexts, given evidence of similar efficacy.
SR | The effects of flow settings during high-flow nasal cannula support for adult subjects
7 Mar, 2023 | 12:40h | UTC
M-A | Early vs. delayed coronary angiography after out-of-hospital cardiac arrest without ST-segment elevation
6 Mar, 2023 | 14:12h | UTCSummary:
This systematic review and meta-analysis of randomized controlled trials evaluated the efficacy and safety of early vs. delayed coronary angiography following an out-of-hospital cardiac arrest in patients without ST elevation on the ECG.
The review included six trials with 1,590 patients and found that early angiography probably has no effect on mortality, survival with good neurologic outcomes, and ICU length of stay, indicating that the procedure should not be routinely recommended for these patients.
Related:
Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest: Results of the Randomized, Multicentric EMERGE Trial – JAMA Cardiology (link to abstract – $ for full-text)
SR | Interventions for preventing and treating kidney disease in IgA vasculitis
3 Mar, 2023 | 13:47h | UTCInterventions for preventing and treating kidney disease in IgA vasculitis – Cochrane Library
SR | Interventions for acute non‐arteritic central retinal artery occlusion
3 Mar, 2023 | 13:36h | UTCInterventions for acute non‐arteritic central retinal artery occlusion – Cochrane Library
Commentary on Twitter
Updated #Cochrane Review finds that treatments for acute non-arteritic #CRAO —the blockage of blood to the retina—are ineffective for visual acuity, and tissue plasminogen activator had serious adverse effectshttps://t.co/RmkLD0te2d@johnclin_ @BrownUResearch @VAResearch pic.twitter.com/BjajHtvWaL
— CochraneEyes (@CochraneEyes) February 2, 2023
SR | Erythromycin prior to endoscopy for acute upper gastrointestinal hemorrhage
3 Mar, 2023 | 13:33h | UTCErythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage – Cochrane Library
SR | Endovascular therapy vs. medical treatment for symptomatic intracranial artery stenosis
3 Mar, 2023 | 13:35h | UTC